Table 2.
Baseline characteristics of patients.
| Characteristics | VonoprazanGroup V(n=18) | RabeprazoleGroup R(n=15) | p value |
|---|---|---|---|
| Sex: Male/Female | 13/5 | 11/4 | 0.75a |
| Age (y): Mean ± SD | 69 ± 9.3 | 70.9 ± 8.8 | 0.57b |
| Body mass index (kg/m2) | 22.7 ± 2.8 | 23.4 ± 2.9 | 0.53b |
| Alcohol: yes/no | 13/5 | 6/9 | 0.13a |
| Smoke: yes/no | 5/13 | 5/10 | 0.97a |
| Diabetes mellitus: +/− | 3/15 | 0/15 | 0.23a |
| Hypertension (%) | 9 (50) | 6 (46) | 0.82a |
| H. pylori infection (%) | 6/15 (40) | 2/13 (15.3) | 0.21a |
Data are expressed as mean ± SD or number of patients (%).
achi-square test, bt-test.
Group V, patient who took vonoprazan; Group R, patient who took rabeprazole.